Home | Sitemap | Contact Us | Login   

    » Home » ABOUT US » Industry Overview

  Industry Overview

Introduction to the pharmaceutical industry worldwide

3 basic categories:

  • Research based pharmaceutical companies
  • Generic drug manufacturers
  • OTC ( Over the counter) pharmaceutical companies. Some companies are active in more than one of the categories mentioned.

Characteristics of research based pharmaceutical companies

  • Innovative. High expenditures into Research and Development
  • Often global players
  • Sophisticated marketing and educational activities
  • Provide value for money

Drop in death rates for diseases treated with pharmaceuticals 1965 - 1996

Disease Treatment % drop in death rate
Rheumatic fever and rheumatic heart disease Antibiotics 83%
Atherosclerosis ACE inhibitors, Beta Blockers, nitrates 74%
Ulcer of stomach and duodenum H2 Blockers, proton pump inhibitors 72%
Ischemic heart disease ACE inhibitors, Beta Blockers, nitrates 62%
Emphysema Anti-inflammatories, bronchodilators 57%

 Source: PhRMA 

R&D expenditures in % of sales

 

US based research based pharmaceutical companies 20.8%
Global pharmaceutical sector 17.3%
Computer software and services 9.3%
Office equipment and services 9.3%
Electrical and electronic devices 6.4%
Telecommunications 5.7%
All industries excluding pharma 4.1%

Source: PhRMA

Company financed R&D by product class in 2000

Central nervous system 22.8 billion MR
Neoplasms, endocrine and metabolicdiseases 19.0 billion MR
Cardiovascular system 15.6 billion MR
Infective and parasitic diseases 13.7 billion MR
Biologicals 9.1 billion MR
Others 93.5 billion MR
Total 164.5 billion MR
Source: PhRMA & IFPMA

Global Pharmaceutical Sales in 2000 by Region in billion MR

580+14%   North America
286+8%     Europe
196+3%    Japan
72+9%      Latin America
71+10%   Asia,Africa,Australia


Pharmaceutical Market in Malaysia

  • Over 100 pharmaceutical companies
  • Most of the world largest pharmaceutical companies are represented
  • Total market estimated at MR 1.4 billion
  • Growth in 2000 of over 15%

Distribution channels of pharmaceuticals in Malaysia

30% Pharmacies
26% Doctors
19% Government hospitals
14% Private hospitals
 11%  others

 



 Print Friendly